SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-16-035265
Filing Date
2016-07-15
Accepted
2016-07-15 12:48:00
Documents
2
Period of Report
2016-03-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20160715_8k.htm 8-K 53282
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 120987
  Complete submission text file 0001437749-16-035265.txt   175712
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 161769241
SIC: 7389 Services-Business Services, NEC